On Friday, Shares of Delta Air Lines, Inc. (NYSE:DAL), gained 1.79% to $46.17.
Grupo Aeromexico, and Delta Air Lines, have filed an application with the Mexican Comision Federal de Competencia Economica (Federal Economic Competition Commission) for a Joint Cooperation Agreement on flights between the United States and Mexico.
Subject to the required economic competition authority’s approvals, the airlines expect to offer an expanded network, enhancing routes and plans, concurrently increasing opportunities to co-locate and invest in airport facilities by improving gates, lounges and the overall connecting experience. Additionally the airlines will enhance joint sales and marketing initiatives in order to benefit consumers.
This application marks a noteworthy step in the process to further deepen the commercial relationship that both airlines have had for over 20 years. As informed on March 31st, in which a similar application was presented to the U.S. Department of Transportation (DOT), this business partnership seeks to offer more travel options and new destinations to passengers in both countries.
Delta Air Lines, Inc. provides planned air transportation for passengers and cargo worldwide. The company operates in two segments, Airline and Refinery. Its route network comprises various gateway airports in Amsterdam, Detroit, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita. The company sells its tickets through various distribution channels, counting mobile and telephone reservations, delta.com, traditional brick and mortar, and online travel agencies.
Shares of Celgene Corporation (NASDAQ:CELG), inclined 1.07% to $113.21, during its last trading session.
Celgene Corporation, declared results from a pre-specified secondary endpoint analysis of MDS-005, a multicenter, randomized, placebo controlled phase III study of REVLMID® (lenalidomide) contrast with placebo in patients with non-del-5q myelodysplastic syndromes (MDS). The analysis was presented during the 13th International Symposium on Myelodysplastic Syndromes.
Results from MDS-005 were originally presented at the 2014 American Society of Hematology annual meeting and stated that significantly more patients treated with lenalidomide achieved red-blood-cell-transfusion independence (RBC-TI) of at least 56 days contrast with placebo (26.9%, [43/160 patients] vs. 2.5%, [2/79 patients]; p<0.001), the primary endpoint of the study.
In the current analysis, presented by Dr. Valeria Santini, HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30 questionnaire at baseline, every 12 weeks thereafter and at discontinuation.
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers.
At the end of Friday’s trade, Shares of Schlumberger Limited (NYSE:SLB), gained 2.44% to $92.43.
On April 30, Subsea Services Alliance, the partnership between Helix Energy Solutions Group, Inc. (HLX), OneSubsea®, a Cameron (CAM) and Schlumberger Limited and Schlumberger, is happy to declare the first joint technology project between OneSubsea and Helix to engineer and manufacture a 15,000-psi intervention riser system.
This jointly developed technology advances the alliance’s objectives to offer well intervention solutions to service the increasing number of high-pressure wells in the subsea environment. The system, which will be accessible on a rental basis in mid-2017, is being engineered and built at OneSubsea facilities in Leeds, UK.
Helix President and Chief Executive Officer, Owen Kratz said, “This new jointly-owned system will allow us to service a wider range of our client’s well stock. It shows that even in a downturn we are able to target new and exciting opportunities.”
OneSubsea Chief Executive Officer, Mike Garding stated, “By combining the operational expertise of Helix Energy Solutions with OneSubsea’s world class engineering and manufacturing capability, we are creating well access and control packages that will expand today’s operating envelope to deeper and higher temperature environments. The declaration for the 15,000-psi intervention riser system is one of the first steps we are taking on the road to become the pioneers in subsea well intervention.”
Schlumberger Limited supplies technology, integrated project administration, and information solutions to the oil and gas exploration and production industries worldwide. The company operates through Reservoir Characterization Group, Drilling Group, and Production Group segments.
Finally, Starbucks Corporation (NASDAQ:SBUX), ended its last trade with 0.87% gain, and closed at $49.78.
The California drought has claimed a new victim.
According to Marketwatch, Starbucks said Friday that it is shifting production of its Ethos Water to Pennsylvania from California due to “serious drought conditions and necessary water conservation efforts.”
The coffee chain said it has already cut its water usage in California by 26% through green building and conservation. Starting in May and for the next six months, Starbucks will start to explore options for a new source and supplier to serve its West Coast distribution.
“We are committed to our mission to be a globally responsible company and to support the people of the state of California as they face this unprecedented drought,” John Kelly, senior vice president of global responsibility and pubic policy, said in a statement.
Starbucks Corporation operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates in four segments: Americas; Europe, Middle East, and Africa; China/Asia Pacific; and Channel Development. The company’s stores offer coffee and tea beverages, packaged roasted whole bean and ground coffees, single serve products, and juices and bottled water.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
